Teva is laying off some 2,900 of its employees worldwide by 2027, corresponding to an approximately 8% reduction in force, company executives announced Wednesday during the company’s first-quarter 2025 earnings report, according to various media reports. According to a subsequent Worker Adjustment and Retraining Notification notice and confirmed by a company spokesperson to BioSpace via email, 54 of the affected employees work in Salt Lake City.
